Related Experiment Video
Updated: May 16, 2026

Robotic-assisted Left Pneumonectomy For Vanishing Lung Syndrome
Published on: January 23, 2026
Treatment of persistent postpneumonectomy empyema by vacuum-assisted management: an analysis of nine patients
Ali Celik1, Erdal Yekeler, Ertan Aydın
1Department of Thoracic Surgery, Atatürk Chest Disease and Thoracic Surgery Training and Research Hospital, Keçiören, Ankara, Turkey.
Background:
Conventional treatment methods in postpneumonectomy empyemas (PPE) are associated with long stay in hospital, poor patient comfort, and high rate of postoperative mortality. Vacuum-assisted management (VAM) may be helpful in solving these problems.
Methods:
VAM was performed on nine patients with PPE in our clinic between July 2010 and September 2011 to provide continuous drainage of empyema in the pouch and to improve empyema with obliteration of the pouch by accelerating tissue granulation.
Results:
All nine patients were men (mean age: 54.5 years; range: 18-68 years). Empyema resolution and obliteration of the pouch were achieved with VAM in the cases with empyema without fistula (n = 7) after the pneumonectomy. In the patients with fistula (n = 2), VAM was performed after closure of the fistula. Mean duration of hospital stay was 36.5 (12-57) days. The treatment was successful in eight of nine patients (88.9%). Mean duration of follow-up in the successfully treated patients was 10.9 (3-17) months.
Conclusion:
Intrathoracic VAM was effective and safe in the treatment of PPE.
Insights
Vacuum-assisted management (VAM) effectively treats postpneumonectomy empyema (PPE), offering a safe and successful alternative to conventional methods. This approach aids in continuous drainage and pouch obliteration, improving patient outcomes.
Area of Science:
- Thoracic Surgery
- Surgical Innovation
- Infectious Disease Management
Background:
- Postpneumonectomy empyema (PPE) presents significant challenges including prolonged hospitalization, patient discomfort, and high mortality rates with conventional treatments.
- Vacuum-assisted management (VAM) emerges as a potential solution to mitigate these adverse outcomes.
Purpose of the Study:
- To evaluate the efficacy and safety of intrathoracic vacuum-assisted management (VAM) for treating postpneumonectomy empyema (PPE).
- To assess VAM's role in continuous drainage and promoting pouch obliteration through enhanced tissue granulation.
Main Methods:
- VAM was applied to nine patients diagnosed with PPE between July 2010 and September 2011.
- The procedure involved continuous drainage of the empyema cavity and facilitation of granulation for pouch obliteration.
Main Results:
- Treatment success was achieved in 88.9% (8 out of 9) of patients.
- In patients without fistula (n=7), VAM led to empyema resolution and pouch obliteration.
- In patients with fistula (n=2), VAM was initiated after fistula closure, also demonstrating success.
- The mean hospital stay was 36.5 days, with a mean follow-up of 10.9 months in successfully treated cases.
Conclusions:
- Intrathoracic vacuum-assisted management (VAM) is an effective and safe therapeutic option for postpneumonectomy empyema (PPE).
- VAM facilitates continuous drainage and promotes healing, leading to successful treatment outcomes in a majority of patients.
Related Concept Videos
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumothorax-II
Clinical Manifestations:
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pneumonia III: Complications and Assessment
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
